Department of Clinical Microbiology

Medicine & Life Sciences

1. Denmark 100%
2. Bacteremia 48%
3. Escherichia coli 41%
4. Staphylococcus aureus 40%
5. Methicillin-Resistant Staphylococcus aureus 40%
6. Anti-Bacterial Agents 35%
7. Cohort Studies 32%
8. Infections 28%
9. Enterococcus faecium 25%
10. Urinary Tract Infections 22%
11. Clone Cells 22%
12. Whole Genome Sequencing 21%
13. Disease Outbreaks 20%
14. Pneumocystis carinii 20%
15. Mortality 18%
16. SARS Virus 18%
17. Genome 18%
18. Vancomycin-Resistant Enterococci 18%
19. Fecal Microbiota Transplantation 17%
20. Population 17%
21. Therapeutics 16%
22. Genes 16%
23. Amdinocillin Pivoxil 15%
24. Methicillin 15%
25. Polymerase Chain Reaction 15%
26. Microbiota 15%
27. Bacteria 14%
28. Epidemiology 14%
29. Microbiology 14%
30. Hepacivirus 14%
31. Coronavirus 13%
32. Blood Culture 12%
33. Child 12%
34. Incidence 12%
35. Genotype 12%
36. Irritable Bowel Syndrome 12%
37. Plasmids 11%
38. Inflammatory Bowel Diseases 11%
39. Klebsiella pneumoniae 11%
40. HIV 11%
41. Cefuroxime 10%
42. Streptococcus pneumoniae 10%
43. Staphylococcus 10%
44. Pseudomonas aeruginosa 10%
45. Escherichia coli Infections 9%
46. Fungemia 9%
47. Severe Acute Respiratory Syndrome 9%
48. Lyme Neuroborreliosis 9%
49. Serogroup 9%
50. Confidence Intervals 9%
51. Observational Studies 9%
52. Placebos 8%
53. Microbial Drug Resistance 8%
54. Pneumocystis Pneumonia 8%
55. Meningitis 8%
56. Chronic Obstructive Pulmonary Disease 8%
57. Penicillins 8%
58. Ulcerative Colitis 8%
59. Dicloxacillin 8%
60. Tazobactam Drug Combination Piperacillin 8%
61. Mutation 8%
62. Retrospective Studies 8%
63. Chromosomes 8%
64. HIV-1 8%
65. Viruses 8%
66. Urine 7%
67. galantide 7%
68. Tuberculosis 7%
69. Amdinocillin 7%
70. Panton-Valentine leukocidin 7%
71. Candida glabrata 7%
72. beta-Lactamases 7%
73. Pulsed Field Gel Electrophoresis 7%
74. Endocarditis 7%
75. Antigens 7%
76. DNA 6%
77. Community-Acquired Infections 6%
78. Pneumonia 6%
79. Sepsis 6%
80. Infection Control 6%
81. Databases 6%
82. Procalcitonin 6%
83. Pandemics 6%
84. Gastrointestinal Microbiome 6%
85. Vancomycin 6%
86. Virulence 6%
87. Pneumococcal Infections 6%
88. Pharynx 6%
89. carbapenemase 6%
90. Point-of-Care Systems 6%
91. Epidemics 6%
92. Diarrhea 6%
93. Prospective Studies 6%
94. Crohn Disease 6%
95. Lactams 6%
96. Real-Time Polymerase Chain Reaction 6%
97. Staphylococcus saprophyticus 6%
98. Ciprofloxacin 5%
99. Delivery of Health Care 5%
100. Nose 5%